The DNA methylation level of MIR193B is higher in atypical WHO GII as compared to benign WHO GI tumors, which corresponds with higher hsa-miR-193b-3p expression in GII than GI meningiomas. This evidence concerns the gene MIR193B and digestive system neoplasm.